Press Releases

Company press releases and official corporate announcements.

A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.

Articles

24,445 total articles

Cipher Digital Provides Second Quarter 2026 Business Update

Cipher Digital Provides Second Quarter 2026 Business Update

Cipher Digital Inc. announced accelerated delivery of initial data center capacity at its Black Pearl campus ahead of schedule, secured an option for a new 900 MW Apollo data center site near San Antonio, Texas, and completed project-level financing fully funding the Stingray data center development. These operational and financial milestones demon…

BellRing Brands Reports Results for the Third Quarter of Fiscal Year 2026; Updates Fiscal Year 2026 Outlook

BellRing Brands Reports Results for the Third Quarter of Fiscal Year 2026; Updates Fiscal Year 2026 Outlook

BellRing Brands Inc. reported Q3 FY 2026 net sales of $570.4 million, a 4% increase year-over-year, with operating profit rising to $65.4 million despite a $10 million inventory charge impacting earnings. The company updated its fiscal year 2026 guidance, projecting net sales between $2.335-$2.375 billion and adjusted EBITDA of $275-$295 million, r…

Rhythm Pharmaceuticals Announces Preliminary Data from Phase 2 Trial that Showed RM-718 Demonstrated Positive Efficacy Signal in Acquired Hypothalamic Obesity

Rhythm Pharmaceuticals Announces Preliminary Data from Phase 2 Trial that Showed RM-718 Demonstrated Positive Efficacy Signal in Acquired Hypothalamic Obesity

Rhythm Pharmaceuticals announced promising preliminary Phase 2 data for RM-718, an investigational MC4R agonist, demonstrating an average 11.6% reduction in BMI at 16 weeks among patients with acquired hypothalamic obesity. These results are comparable to existing treatments, with minimal adverse effects such as mild injection site hyperpigmentatio…

ScottsMiracle-Gro Announces Financial Targets and Capital Allocation Strategy During Investor Day 2026 at NYSE

ScottsMiracle-Gro Announces Financial Targets and Capital Allocation Strategy During Investor Day 2026 at NYSE

The Scotts Miracle-Gro Company announced its mid-range financial targets and capital allocation strategy for fiscal years 2027 to 2029 during its Investor Day 2026 at the NYSE. The company outlined its SMG 2.0 growth strategy focusing on portfolio innovation, omnichannel expansion, market penetration, and operational excellence through technology. …

Kimco Realty® Announces Second Quarter 2026 Results

Kimco Realty® Announces Second Quarter 2026 Results

Kimco Realty Corporation, a leading US REIT specializing in open-air, grocery-anchored shopping centers, announced solid second quarter 2026 results highlighted by record portfolio occupancy of 96.4%, 4.5% growth in funds from operations (FFO) per share, and a 12% dividend increase. The company also raised its full-year 2026 net income and FFO outl…

Senmiao Technology Limited Engages Strategic Advisory Firm to Support Government Relations and Strategic Advisory Efforts

Senmiao Technology Limited Engages Strategic Advisory Firm to Support Government Relations and Strategic Advisory Efforts

Senmiao Technology Limited (Nasdaq: AIHS) has hired a strategic government relations advisory firm led by Justin Evans to aid in site development, permitting, incentives, and government stakeholder engagement for its AI data center (AIDC) projects in the United States. This partnership aims to support the company's expansion efforts, including its …

Westlake Corporation Reports Second Quarter 2026 Results

Westlake Corporation Reports Second Quarter 2026 Results

Westlake Corporation announced its second quarter 2026 financial results, posting net income of $260 million and EBITDA of $679 million, marking a significant improvement over previous quarters and last year. The company reduced debt by $500 million, returned $99 million to shareholders, and reported increased sales volumes in both Housing and Infr…

Chatham Lodging Announces Second Quarter 2026 Results

Chatham Lodging Announces Second Quarter 2026 Results

Chatham Lodging Trust, a REIT specializing in upscale hotels, announced robust second quarter 2026 financial results showing a 3% increase in RevPAR and a 22% surge in AFFO per diluted share to $0.48. Key markets including Silicon Valley and newly acquired hotels outperformed expectations, contributing to margin expansions and solid net income rise…

Vivid Seats Reports Second Quarter 2026 Results

Vivid Seats Reports Second Quarter 2026 Results

Vivid Seats Inc. reported second quarter 2026 results with marketplace gross order value (GOV) of $659.4 million and revenues of $129.9 million. The company posted a net loss of $14.3 million and adjusted EBITDA of $12.6 million, improved sequentially due to strong demand from the FIFA World Cup. Despite growth, overall marketplace orders and reven…

Apollo Reports Second Quarter 2026 Results

Apollo Reports Second Quarter 2026 Results

Apollo Global Management, Inc. announced strong second quarter 2026 results, showcasing record earnings across its Asset Management and Retirement Services divisions. The company declared a cash dividend of $0.5625 per share, reflecting its robust financial performance and ongoing commitment to shareholders. Apollo continues to expand its alternati…

Westlake Chemical Partners LP Announces Second Quarter 2026 Results

Westlake Chemical Partners LP Announces Second Quarter 2026 Results

Westlake Chemical Partners LP announced its Q2 2026 financial results, reporting net income of $14.2 million and declaring its 48th consecutive quarterly distribution of $0.4714 per unit. The company benefited from higher third-party ethylene prices and stable cash flows due to an ethylene sales agreement with Westlake Corporation. Operating cash f…

Ingredion Incorporated Reports Second Quarter 2026 Results

Ingredion Incorporated Reports Second Quarter 2026 Results

Ingredion Incorporated announced its second quarter 2026 financial results showing a 1% increase in net sales driven by volume growth in Texture & Healthful Solutions and favorable foreign exchange effects despite a 31% decline in reported operating income. The company reaffirmed its full-year 2026 guidance reflecting the impact of the sale of a ma…

Katapult Reports Second Quarter Results

Katapult Reports Second Quarter Results

Katapult Holdings, Inc. reported a 5% increase in gross originations for Q2 2026, marking its 15th consecutive quarter of growth. Revenue grew 4%, and adjusted EBITDA increased nearly 280%. Net loss improved by 44% year-over-year due to lower interest expense after extinguishing its term loan. Katapult has a pending merger with The Aaron’s Company …

Fusemachines Closes Up to $10.66 Million Investment at $4.20 per Share for Growth Capital from Existing Investor Meteora Capital

Fusemachines Closes Up to $10.66 Million Investment at $4.20 per Share for Growth Capital from Existing Investor Meteora Capital

Fusemachines Inc., a Nasdaq-listed provider of enterprise AI products and services, announced a $2.5 million convertible note investment with $4.20 fixed conversion and warrant exercise prices from existing investor Meteora Capital. With additional warrant exercises, Fusemachines could raise up to $10.66 million to accelerate development and commer…

CervoMed Announces Neflamapimod Awarded Innovation Passport Designation Under the UK Innovative Licensing and Access Pathway (ILAP) for Treatment of Dementia with Lewy Bodies (DLB)

CervoMed Announces Neflamapimod Awarded Innovation Passport Designation Under the UK Innovative Licensing and Access Pathway (ILAP) for Treatment of Dementia with Lewy Bodies (DLB)

CervoMed Inc. announced that its oral drug candidate, neflamapimod, has been granted an Innovation Passport designation under the UK Innovative Licensing and Access Pathway (ILAP) to support accelerated regulatory review and patient access for the treatment of Dementia with Lewy Bodies (DLB). This designation recognizes neflamapimod's potential as …

SRX Global Acquires Stake in Vistagen Therapeutics (NASDAQ: VTGN)

SRX Global Acquires Stake in Vistagen Therapeutics (NASDAQ: VTGN)

SRX Global Inc., an AI-driven investment platform, announced the acquisition of a stake in Vistagen Therapeutics (NASDAQ: VTGN), a clinical-stage biopharmaceutical company focused on intranasal neuroscience product candidates. SRX views Vistagen shares as undervalued and plans to engage with its leadership to unlock shareholder value, leveraging it…

Prologis, Inc. Announces Recommended Combination

Prologis, Inc. Announces Recommended Combination

Prologis, Inc., the leading global logistics real estate investment trust (REIT), announced it has reached a recommended agreement to acquire the UK-based SEGRO plc through an all-share offer with a partial cash alternative. The transaction values SEGRO at approximately £14 billion, representing a significant premium to SEGRO's recent share prices …

IQM Quantum Computers Reports First Earnings as Public Company, Reporting First Half and Second Quarter 2026 Results, and Initiates FY 2026 Guidance Supported by Over EUR 102 million Order Backlog

IQM Quantum Computers Reports First Earnings as Public Company, Reporting First Half and Second Quarter 2026 Results, and Initiates FY 2026 Guidance Supported by Over EUR 102 million Order Backlog

IQM Quantum Computers Plc, a Finnish-based global leader in superconducting quantum computers, announced its first earnings as a public company for H1 and Q2 2026. The company reported EUR 8.9 million in revenues and an operating loss of EUR 60.5 million, supported by a substantial cash balance of EUR 309.4 million post listing. IQM expanded its ma…